WASHINGTON (AP) — The Food and Drug Administration has authorized a booster dose of the COVID-19 vaccine made by Novavax. That company began offering its two-dose primary vaccinations in the U.S. over the summer. The FDA said the new booster option is for adults who can't get one of the updated omicron-targeting Pfizer or Moderna boosters for medical or accessibility reasons — or who otherwise wouldn't seek a COVID-19 booster shot at all. It's to be used only as a first booster, not for people who've already had one or more booster doses already.
vaccine
A coronavirus vaccine is now available in Russia.
Posted at
and last updated
Copyright 2022 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.
